logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
D

David J. Barton

university of pittsburgh school of medicine
H指数:14
被引数:844

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Neurofilament Light Protein: A Marker for Injury Severity, Clinical Course, and Outcome Following Moderate to Severe Traumatic Brain Injury

神经丝轻链蛋白：中度至重度创伤性脑损伤后损伤严重程度、临床过程和预后的标志物

Neurocritical Care
IF3.6
2026-07-130
OA
Spyridoula Tsetsou; Leah E. McQuillan; Vishruth P. Reddy; David J. Barton; Damon G. Lamb; Firas Kobeissy; Guangzheng Cai; Richard Rubenstein; Kevin K. W. Wang; John B. Williamson; Claudia S. Robertson; Amy K. Wagner
Traumatic Brain Injury Severity Measured by Clinical; Radiographical; and Blood Biomarker Measures Is Associated with Non-Neurological Organ Dysfunction: A Secondary Analysis of ProTECT III and Bio-ProTECT

通过临床、影像学和血液生物标志物测量得出的创伤性脑损伤严重程度与非神经器官功能障碍相关：ProTECT III和Bio-ProTECT研究的二次分析

Journal of Neurotrauma
IF3.8
2025-08-070
PRE
David J. Barton; Erica K. Fan; Ian G. Gober; Nabil Awan; Raj G. Kumar; Jenna C. Carlson; Michael R. Frankel; David W. Wright; Amy K. Wagner
Assessment of an organizational effort to increase emergency medicine faculty on National Institutes of Health study sections

评估在国立卫生研究院研究部门增加急诊医学院的组织努力

ACADEMIC EMERGENCY MEDICINE
IF3.2
2024-07-260
PRE
Pulcini, Christian D.; Barton, David J.; Cassara, Michael; Davis, Joshua J.; DeMasi, Stephanie C.; Durant, Edward J.; Garg, Nidhi; Greineder, Colin; McMillian, Melissa; Paxton, James H.; Puskarich, Michael A.; Vogel, Jody A.; Wong, Ambrose H.; Sharp, Willard W.
Parallel Cerebrospinal Fluid and Serum Temporal Profile Assessment of Axonal Injury Biomarkers Neurofilament-Light Chain and Phosphorylated Neurofilament-Heavy Chain: Associations With Patient Outcome in Moderate-Severe Traumatic Brain Injury
JOURNAL OF NEUROTRAUMA
IF3.8
2024-07-018
PRE
Wang, Kevin K. W.; Barton, David J.; McQuillan, Leah E.; Kobeissy, Firas; Cai, Guangzheng; Xu, Haiyan; Yang, Zhihui; Trifilio, Erin; Williamson, John B.; Rubenstein, Richard; Robertson, Claudia S.; Wagner, Amy K.
nab-paclitaxel plus carboplatin or gemcitabine vs gemcitabine/carboplatin as first-line treatment for patients with triple-negative metastatic breast cancer: Results from the randomized phase 2 portion of the tnAcity trial
CANCER RESEARCH
IF16.6
2017-02-150
PRE
Yardley, D.; Coleman, R.; Conte, P.; Cortes, J.; Brufsky, A.; Shtivelband, M.; Young, R.; Bengala, C.; Ali, H.; Eakel, J.; Schneeweiss, A.; Merino, L. de la Cruz; Wilks, S.; O'Shaugnessy, J.; Gluck, S.; Li, H.; Beck, R.; Barton, D.; Harbeck, N.

研究方向

暂未获取到该数据
A
Amy K. Wagner
H 指数:54论文数:291被引数:9,828
K
Kevin Wang
H 指数:104论文数:899被引数:5.0万
N
Nabil Awan
H 指数:13论文数:38被引数:814
R
Raj G. Kumar
H 指数:25论文数:145被引数:2,256
L
Leah E. McQuillan
H 指数:5论文数:13被引数:72
B
Byung‐Mo Oh
H 指数:33论文数:264被引数:3,939
M
Mark P. Burns
H 指数:33论文数:85被引数:5,292
R
Richard Rubenstein
H 指数:46论文数:194被引数:8,153
J
Jonathan Elmer
H 指数:43论文数:383被引数:6,714
J
John B. Williamson
H 指数:42论文数:437被引数:6,803